Mr. Shaun Flanagan:

There is not a robust estimate of that. It was work that the clinical advisory group tried to do but it was not able to provide a robust estimate. This comes down to the challenge of prognostication: the longer the period of life that one is trying to estimate, the wider the confidence intervals. For the 12 months we award some 3,500 cards in respect of that cohort, so one must assume it would be 3,500 when it gets up to full speed. This is a plus, and it would probably be a bit more than that due to the wider confidence intervals.